Biotech Values

[GrthzGd]

Jack Lew's "rule," published as it was to become effective immediately without prior notice or opportunity to comment, will probably generate a lawsuit seeking to enjoin its effectiveness pending a determination of whether it exceeds the original enabling legislation. However, any uncertainty that prevails while the suit is pending may be enough to queer the MYL/ABT, and other pending cross border acquisitions. Thx go to North40000 for his private comment.